Early growth response transcription factors: Key mediators of fibrosis and novel targets for anti-fibrotic therapy

Matrix Biology

Volumn 30, Issue 4, 2011, Pages 235-242

  Bhattacharyya, Swati ^a   Wu, Minghua ^a   Fang, Feng ^a   Tourtellotte, Warren ^a   Feghali Bostwick, Carol ^b   Varga, John ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Egr 1; Fibroblast; Fibrosis; Scleroderma (systemic sclerosis); TGF

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA;

ATHEROSCLEROSIS; BIOLOGICAL ACTIVITY; BIOSYNTHESIS; FIBROGENESIS; FIBROSING ALVEOLITIS; FIBROSIS; GENE; GENE EXPRESSION; HUMAN; INFLAMMATION; ISCHEMIA; MULTIGENE FAMILY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SCLERODERMA; TISSUE REPAIR;

ANIMALS; CONNECTIVE TISSUE; EARLY GROWTH RESPONSE PROTEIN 1; EARLY GROWTH RESPONSE TRANSCRIPTION FACTORS; FIBROBLASTS; FIBROSIS; HOMEOSTASIS; HUMANS; P300-CBP TRANSCRIPTION FACTORS; PROTO-ONCOGENE PROTEINS C-ABL; REPRESSOR PROTEINS; SCLERODERMA, SYSTEMIC; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; MUS;

EID: 79958108760     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2011.03.005     Document Type: Review

References (79)

1. Baron V., Adamson E.D., Calogero A., Ragona G., Mercola D. The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther. 2006, 13:115-124.
2. Bea F., Blessing E., Shelley M.I., Shultz J.M., Rosenfeld M.E. Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation. Atherosclerosis 2003, 167:187-194.
3. Beattie J., Allan G.J., Lochrie J.D., Flint D.J. Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem. J. 2006, 395:1-19.
4. Bhattacharyya S., Ghosh A.K., Pannu J., Mori Y., Takagawa S., Chen G., Trojanowska M., Gilliam A.C., Varga J. Fibroblasts expression of the coactivator p300 governs the intensity of profibrotic response to TGF-β. Arthritis Rheum. 2005, 52:1248-1258.
5. Bhattacharyya S., Chen S.J., Wu M., Blankenship M.W., Ning H., Lakos G., Mori Y., Chang E., Nihijima C., Takehara K., Feghali-Bostwick C., Varga J. Smad-Independent Transforming Growth Factor-β Regulation of Early Growth Response-1 and sustained expression in fibrosis. Implications for Scleroderma. Am. J. Path. 2008, 173:1085-1099.
6. Bhattacharyya S., Ishida W., Wu M., Wilkes M., Mori Y., Hinchcliff M., Leof E., Varga J. A non-Smad mechanism of fibroblast activation by transforming growth factor-b via c-Abl and Egr-1: selective modulation by imatinib mesylate. Oncogene 2008, 1-13.
7. Bhattacharyya S., Wei J., Melichian D.S., Milbrandt J., Takehara K., Varga J. The transcriptional cofactor Nab2 is induced by TGF-ß and suppresses fibroblast activation: physiological roles and impaired expression in scleroderma. PLoS One 2009, 26(4):e7620.
8. Boon K., Bailey N.W., Yang J., Steel M.P., Groshong S., Kervitsky D., Brown K.K., Schwarz M.I., Schwartz D.A. Molecular phenotypes distinguish patients with relatively stable from progressive idiopathic pulmonary fibrosis (IPF). PLoS One 2009, 4(4):e5134.
9. Bot P.T., Hoefer I.E., Sluijter J.P., van Vliet P., Smits A.M., Lebrin F., Moll F., de Vries J.P., Doevendans P., Piek J.J., Pasterkamp G., Goumans M.J. Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques. Stroke 2009, 40:439-447.
10. Buchwalter G., Gross C., Wasylyk B. Ets ternary complex transcription factors. Gene 2004, 324:1-14.
11. Cao X., Mahendran R., Guy G.R., Tan Y.H. Detection and characterization of cellular EGR-1 binding to its recognition site. J. Biol. Chem. 1993, 268:16949-16957.
12. Chen S.J., Ning H., Ishida W., Sodin-Semrl S., Takagawa S., Mori Y., Varga J. The early-immediate gene EGR-1 is induced by transforming growth factor-beta and mediates stimulation of collagen gene expression. J. Biol. Chem. 2006, 281:21183-21197.
13. Cho S.J., Kang M.J., Homer R.J., Kang H.R., Zhang X., Lee P.J., Elias J.A., Lee C.G. Role of early growth response-1 (Egr-1) in interleukin-13-induced inflammation and remodeling. J. Biol. Chem. 2006, 2006(281):8161-8168.
14. Collins S., Lutz M.A., Zarek P.E., Anders R.A., Kersh G.J., Powell J.D. Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. Eur. J. Immunol. 2008, 38:528-536.
15. Daniels C.E., Wilkes M.C., Edens M., Kottom T.J., Murphy S.J., Limper A.H., et al. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J. Clin. Invest. 2004, 114:1308-1316.
16. Diebold I., Petry A., Hess J., Görlach A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol. Biol. Cell 2010, 21:2087-2096.
17. Distler J.H., Jungel A., Huber L.C., Schulze-Horsel U., Zwerina J., Gay R.E., et al. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum. 2007, 56:311-322.
18. Djordjevic T., BelAiba R.S., Bonello S., Pfeilschifter J., Hess J., Görlach A. Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscle. Thromb. Vasc. Biol. 2005, 25:519-525.
19. Du B., Fu C., Kent K.C., Bush H., Schulick A.H., Kreiger K., Collins T., McCaffrey T.A. Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor. J. Biol. Chem. 2000, 275:39039-39047.
20. Ehrengruber M.U., Muhlebach S.G., Sohrman S., Leutenegger C.M., Lester H.A., et al. Modulation of early growth response (EGR) transcription factor-dependent gene expression by using recombinant adenovirus. Gene 2000, 258:63-69.
21. Fang F., Ooka K., Bhattacharyya S., Wei J., Wu M., Du P., Lin S., Del Galdo F., Feghali-Bostwick C.A., Varga J. The early growth response gene Egr-2 (Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses. Am. J. Path. 2011, 178:2077-2090.
22. Farivar A.S., MacKinnon-Patterson B., Barnes A.D., Mulligan M.S. The effect of anti-inflammatory properties of mycophenolate mofetil on the development of lung reperfusion injury. J. Heart Lung Transplant. 2005, 24:2235-2242.
23. Farivar A.S., Mackinnin-Patterson B.C., Barnes A.D., McCourtie A.S., Mulligan M.S. Cyclosporine modulates the response to hypoxia-reoxygenation in pulmonary artery endothelial cells. Ann. Thorac. Surg. 2005, 79:1010-1016.
24. Fichtner-Feigl S., Young C.A., Kitani A., Geissler E.K., Schlitt H.J., Strober W. IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 2008, 135:2003-2013.
25. Friedrich B., Janessa A., Artunc F., Aicher W.K., Müller G.A., Lang F., Risler T., Alexander D. DOCA and TGF-beta induce early growth response gene-1 (Egr-1) expression. Cell. Physiol. Biochem. 2008, 22:465-474.
26. Gabrielli A., Avvedimento E.V., Krieg T. Scleroderma. N. Engl. J. Med. 2009, 360:1989-2003.
27. Gaggioli C., Deckert M., Robert G., Abbe P., Batoz M., Ehrengruber M.U., Ortonne J.P., Ballotti R., Tartare-Deckert S. HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1. Oncogene 2005, 24:1423-1433.
28. Gashler A., Sukhatme V.P. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 1995, 50:191-224.
29. Ghosh A.K., Varga J. The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J. Cell. Physiol. 2007, 213:663-671.
30. Ghosh A.K., Yuan W., Mori Y., Varga J. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-ßeta involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 2000, 19:3546-3555.
31. Grigoryev D.N., Mathai S.C., Fisher M.R., Girgis R.E., Zaiman A.L., Housten-Harris T., Cheadle C., Gao L., Hummers L.K., Champion H.C., Garcia J.G., Wigley F.M., Tuder R.M., Barnes K.C., Hassoun P.M. Identification of candidate genes in scleroderma-related pulmonary arterial hypertension. Transl. Res. 2008, 151:197-207.
32. Grotegut S., von Schweinitz D., Christofori G., Lehembre F. Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J. 2006, 25:3534-3545.
33. Guha M., O'Connell M.A., Pawlinski R., Hollis A., McGovern P., Yan S.F., Stern D., Mackman N. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 2001, 98:1429-1439.
34. Gupte S.A., Wolin M.S. Oxidant and redox signaling in vascular oxygen sensing: implications for systemic and pulmonary hypertension. Antioxid. Redox Signal. 2008, 10:1137-1152.
35. Hasan R.N., Schafer A.I. Hemin Upregulates Egr-1 Expression in Vascular Smooth Muscle Cells via ROS ERK-1/2 Elk-1 and NF-{kappa}B. Circ. Res. 2008, 102:42-50.
36. Hecker L., Vittal R., Jones T., Jagirdar R., Luckhardt T.R., Horowitz J.C., Pennathur S., Martinez F.J., Thannickal V.J. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat. Med. 2009, 15:1077-1081.
37. Hjoberg J., Le L., Imrich A., Subramaniam V., Mathew S.I., Vallone J., Haley K.J., Green F.H., Shore S.A., Silverman E.S. Induction of early growth-response factor 1 by platelet-derived growth factor in human airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 286:L817-L825.
38. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J. Clin. Invest. 2009, 119:1417-1419.
39. Kaufmann K., Thiel G. Epidermal growth factor and thrombininduced proliferation of immortalized human keratinocytes is coupled to the synthesis of Egr-1, a zinc finger transcriptional regulator. J. Cell. Biochem. 2002, 85:381-391.
40. Khachigian L.M. Early growth response-1 in cardiovascular pathobiology. Circ. Res. 2006, 98:186-191.
41. Khachigian L.M., Collins T. Early growth response factor 1: a pleiotropic mediator of inducible gene expression. J. Mol. Med. 1998, 76:613-616.
42. Kharbanda S.R., Ren P., Pandey T.D., Shafman S.M., Feller R.R., Weichselbaum, et al. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 1995, 376:785-788.
43. Kramer E.L., Mushaben E.M., Pastura P.A., Acciani T.H., Deutsch G.H., Khurana Hershey G.K., Korfhagen T.R., Hardie W.D., Whitsett J.A., Le Cras T.D. Egr-1 Suppresses EGFR-mediated airway hyperresponsiveness and lung remodeling in mice. Am. J. Respir. Cell Mol. Biol. 2009, 41:415-425.
44. Krones-Herzig A., Mittal S., Yule K., Liang H., English C., Urcis R., Soni T., Adamson E.D., Mercola D. Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. Cancer Res. 2005, 65:5133-5143.
45. Kumbrink J., Kirsch K.H., Johnson J.P. EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin. J. Cell. Biochem. 2010, 111:207-217.
46. Le N., Nagarajan R., Wang J.Y., Araki T., Schmidt R.E., Milbrandt J. Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc. Natl. Acad. Sci. USA. 2005, 102:2596-2601.
47. Lee S.L., Sadovsky Y., Swirnoff A.H., Polish J.A., Goda P., Gavrilina G., Milbrandt J. Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science. 1996, 273:1219-1221.
48. Lee C.G., Cho S.J., Kang M.J., Chapoval S.P., Lee P.J., Noble P.W., Yehualaeshet T., Lu B., Flavell R.A., Milbrandt J., Homer R.J., Elias J.A. Early growth response gene 1-mediated apoptosis is essential for transforming growth factor beta1-induced pulmonary fibrosis. J. Exp. Med. 2004, 200:377-389.
49. Li C.J., Ning W., Matthay M.A., Feghali-Bostwick C.A., Choi A.M. MAPK pathway mediates EGR-1-HSP70-dependent cigarette smoke-induced chemokine production. Am J Physiol Lung Cell Mol Physio. 2007, 292:L1297-L1303.
50. Lohoff M., Giaisi M., Köhler R., Casper B., Krammer P.H., Li-Weber M. Early growth response protein-1 (Egr-1) is preferentially expressed in T helper type 2 (Th2) cells and is involved in acute transcription of the Th2 cytokine interleukin-4. J. Biol. Chem. 2010, 285:1643-1652.
51. Lugo T.G., Pendergast A.M., Muller A.J., Witte O.N. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 1990, 247:1079-1082.
52. Midgley V.C., Levon M. Fibroblast growth factor-2 induction of platelet-derived growth factor-C chain transcription in vascular smooth muscle cells is ERK-dependent but not JNK-dependent and mediated by Egr-1. J. Biol. Chem. 2004, 279:40289-40295.
53. Milano A., Pendergrass S.A., Sargent J.L., George L.K., McCalmont T.H., Connolly M.K., Whitfield M.L. Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One 2008, 16, 3(7). e2696.
54. Okada M., Wen F., Yan S.F. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEB J. 2002, 16:1861-1868.
55. Pritchard M.T., Cohen J.I., Roychowdhury S., Pratt B.T., Nagy L.E. Early growth response-1 attenuates liver injury and promotes hepatoprotection after carbon tetrachloride exposure in mice. J. Hepatol. 2010, 53:655-662.
56. Rahimi R.A., Leof E.B. TGF-beta signaling: a tale of two responses. J. Cell. Biochem. 2007, 102:593-608.
57. Rössler O.G., Thiel G. Thrombin induces Egr-1 expression in fibroblasts involving elevation of the intracellular Ca2+ concentration, phosphorylation of ERK and activation of ternary complex factor. BMC Mol. Biol. 2009, 10:40.
58. Rowley J.D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrinefluorescence and Giemsa staining. Nature 1973, 243:290-293.
59. Russo M.W., Sevetson B.R., Milbrandt J. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc. Natl. Acad. Sci. USA. 1995, 92:6873-6877.
60. Saadane N., Alpert L., Chalifour L.E. Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 2000, 278:H796-H805.
61. Sargent J.L., Milano A., Bhattacharyya S., Varga J., Connolly M.K., Chang H.W., Whitfield M.L. A TGFβ-responsive Gene Signature is Associated with a subset of diffuse Scleroderma with increased disease severity. J. Inves. Derm. 2009, 2009(130):694-705.
62. Sela U., Dayan M., Hershkoviz R., Lider O., Mozes E. A peptide that ameliorates lupus up-regulates the diminished expression of early growth response factors 2 and 3. J. Immunol. 2008, 180:1584-1591.
63. Srinivasan R., Mager G.M., Ward R.M., Mayer J., Svaren J. NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex. J. Biol. Chem. 2006, 281:15129-15137.
64. Sturrock A., Cahill B., Norman K., Huecksteadt T.P., Hill K., Sanders K., Karwande S.V., Stringham J.C., Bull D.A., Gleich M., Kennedy T.P., Hoidal J.R. Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006, 290:L661-L673.
65. Svaren J., Sevetson B.R., Apel E.D., Zimonjic D.B., Popescu N.C., Milbrandt J. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol. 1996, 16:3545-3553.
66. Svaren J., Sevetson B.R., Golda T., Stanton J.J., Swirnoff A.H., Milbrandt J. Novel mutants of NAB corepressors enhance activation by Egr transactivators. EMBO J. 1998, 17:6010-6019.
67. Tureyen K., Brooks N., Bowen K., Svaren J., Vemuganti R. Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. J. Neurochem. 2008, 105:1313-1324.
68. Wang S., Wilkes M.C., Leof E.B., Hirschberg R. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo. FASEB J. 2005, 19:1-11.
69. Wei J., Bhattacharyya S., Tourtellotte W.G., Varga J. Fibrosis in systemic sclerosis: Emerging concepts and implications for targeted therapy. Autoimmun. Rev. 2011, 10:267-275.
70. Wilkes M.C., Leof E.B. Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures. J. Biol. Chem. 2006, 281:27846-27854.
71. Wu M., Varga J. In perspective: murine models of scleroderma. Curr. Rheumatol. Rep. 2008, 10:173-182.
72. Wu M., Melichian D.S., Chang E., Warner-Blankenship M., Ghosh A.K., Varga J. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma. Am. J. Pathol. 2009, 174:519-533.
73. Wu M., Melichian D.S., de la Garza M., Gruner K., Bhattacharyya S., Barr L., Nair A., Shahrara S., Sporn P.H., Mustoe T.A., Tourtellotte W.G., Varga J. Essential roles for Early growth response transcription factor egr-1 in tissue fibrosis and wound healing. Am. J. Pathol. 2009, 175:1041-1065.
74. Wynn T.A. Fibrosis under arrest. Nat. Med. 2010, 16:523-525.
75. Yan S.F., Fujita T., Lu J., Okada K., Shan Zou Y., Mackman N., Pinsky D.J., Stern D.M. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat. Med. 2000, 6:1355-1361.
76. Yasuoka H., Hsu E., Ruiz X.D., Steinman R.A., Choi A.M., Feghali-Bostwick C.A. The fibrotic phenotype induced by IGFBP-5 is regulated by MAPK activation and egr-1-dependent and -independent mechanisms. Am. J. Pathol. 2009, 175:605-615.
77. Yu J., de Belle I., Liang H., Adamson E.D. Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses. Mol. Cell 2004, 15:83-94.
78. Yu H.W., Liu Q.F., Liu G.N. Positive regulation of the Egr-1/osteopontin positive feedback loop in rat vascular smooth muscle cells by TGF-beta, ERK, JNK, and p38 MAPK signaling. Biochem. Biophys. Res. Commun. 2010, 396:451-456.
79. Zhu B., Symonds A.L., Martin J.E., Kioussis D., Wraith D.C., Li S., Wang P. Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J. Exp. Med. 2008, 205:2295-2307.